CD8A and melanoma: This preterminally differentiated phenotype has been observed in antigen (Ag)‐specific CD8+ T cells recovered from both tumor‐involved lymph nodes (TILN) and tumor‐free lymph nodes (TFLN) of melanoma patients [9].